MRD detection in acute lymphoblastic leukemia patients using Ig/TCR gene rearrangements as targets for real-time quantitative PCR

Methods in Molecular Biology

Volumn 538, Issue , 2009, Pages 115-150

  Van Der Velden, Vincent H J ^a   Van Dongen, Jacques J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Acute lymphoblastic leukemia (ALL); IGH; IGK; IGL; Immunoglobulin (Ig); Junctional region; Minimal residual disease (MRD); Quantitative range; Real time quantitative PCR (RQ PCR); sensitivity; T cell receptor (TCR); TCRB; TCRD; TCRG

Indexed keywords

PRIMER DNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW; CHEMISTRY; GENE REARRANGEMENT; GENETICS; HUMAN; IMMUNOGLOBULIN GENE; METHODOLOGY; MINIMAL RESIDUAL DISEASE; PATHOLOGY; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE RECEPTOR GENE;

BONE MARROW; DNA PRIMERS; GENE REARRANGEMENT; GENES, IMMUNOGLOBULIN; GENES, T-CELL RECEPTOR; HUMANS; NEOPLASM, RESIDUAL; POLYMERASE CHAIN REACTION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; SENSITIVITY AND SPECIFICITY;

EID: 65649143517     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-418-6_7     Document Type: Article

References (58)

1. van Dongen, J. J. M., Seriu, T., Panzer- Grumayer, E. R., Biondi, A., Pongers-Willemse, M. J., Corral, L., Stolz, F., Schrappe, M., Masera, G., Kamps, W. A., Gadner, H., van Wering, E. R., Ludwig, W. D., Basso, G., de Bruijn, M. A., Cazzaniga, G., Hettinger, K., van der Does-van den Berg, A., Hop, W. C., Riehm, H., and Bartram, C. R. (1998) Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 352, 1731-1738. (Pubitemid 28534955)
2. Cave, H., van der Werff ten Bosch, J., Suciu, S., Guidal, C., Waterkeyn, C., Otten, J., Bakkus, M., Thielemans, K., Grandchamp, B., and Vilmer, E. (1998) Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer-Childhood Leukemia Cooperative Group. New England Journal of Medicine 339, 591-598.
3. Coustan-Smith, E., Sancho, J., Hancock, M. L., Boyett, J. M., Behm, F. G., Raimondi, S. C., Sandlund, J. T., Rivera, G. K., Rubnitz, J. E., Ribeiro, R. C., Pui, C. H., and Campana, D. (2000) Clinical importance of minimal residual disease in childhood acute lymphob- lastic leukemia. Blood 96, 2691-2696.
4. Panzer-Grumayer, E. R., Schneider, M., Pan- zer, S., Fasching, K., and Gadner, H. (2000) Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia. Blood 95, 790-794. (Pubitemid 30062697)
5. Goulden, N., Bader, P., Van Der Velden, V., Moppett, J., Schilham, M., Masden, H. O., Krejci, O., Kreyenberg, H., Lankester, A., Revesz, T., Klingebiel, T., and Van Dongen, J. (2003) Minimal residual disease prior to stem cell transplant for childhood acute lymphob-lastic leukaemia. British Journal of Haematol-ogy 122, 24-29. (Pubitemid 36819335)
6. Schrappe, M. (2002) Risk-adapted therapy: lessons from childhood acute lymphoblastic leukemia. Hematological Journal 3, 127-132.
7. van der Velden, V. H. J., Hochhaus, A., Caz- zaniga, G., Szczepanski, T., Gabert, J., and van Dongen, J. J. M. (2003) Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia 17, 1013-1034. (Pubitemid 36722231)
8. Szczepanski, T., Flohr, T., van der Velden, V. H. J., Bartram, C. R., and van Dongen, J. J. M. (2002) Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia. Best Practice & Research. Clinical Haematology 15, 37-57.
9. van der Velden, V. H., Panzer-Grumayer, E. R., Cazzaniga, G., Flohr, T., Sutton, R., Schrauder, A., Basso, G., Schrappe, M., Wijkhuijs, J. M., Konrad, M., Bartram, C. R., Masera, G., Biondi, A., and van Dongen, J. J. (2007) Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multicenter setting. Leukemia 21, 706-713. (Pubitemid 46444554)
10. Szczepanski, T., van der Velden, V. H., and van Dongen, J. J. (2006) Flow-cytometric immunophenotyping of normal and malignant lymphocytes. Clinical Chemistry and Laboratory Method 44, 775-796.
11. Szczepanski, T., van der Velden, V. H., and van Dongen, J. J. (2003) Classification systems for acute and chronic leukaemias. Best Practice & Research. Clinical Haematology 16, 561-582.
12. Langerak, A. W., Szczepanski, T., van der Burg, M., Wolvers-Tettero, I. L., and van Dongen, J. J. (1997) Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia 11, 2192-2199. (Pubitemid 28043709)
13. Szczepanski, T., van der Velden, V. H. J., Hoogeveen, P. G., De Bie, M., Jacobs, D. C. H., Van Wering, E. R., and van Dongen, J. J. M. (2004) V{delta}2-J{alpha} gene rearrangements are frequent in precursor-B-acute lymphoblastic leukemia but rare in normal lymphoid cells. Blood 103, 3798-3804. (Pubitemid 38596298)
14. Szczepanski, T., Langerak, A. W., Wolvers- Tettero, I. L., Ossenkoppele, G. J., Verhoef, G., Stul, M., Petersen, E. J., de Bruijn, M. A., van't Veer, M. B., and van Dongen, J. J. M. (1998) Immunoglobulin and T cell receptor gene rearrangement patterns in acute lym-phoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease. Leukemia 12, 1081-1088. (Pubitemid 28349804)
15. Szczepanski, T., Beishuizen, A., Pongers-Wil- lemse, M. J., Hahlen, K., Van Wering, E. R., Wijkhuijs, A. J., Tibbe, G. J., De Bruijn, M. A., and Van Dongen, J. J. M. (1999) Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease. Leukemia 13, 196-205. (Pubitemid 29092652)
16. Szczepanski, T., Pongers-Willemse, M. J., Langerak, A. W., Harts, W. A., Wijkhuijs, A. J., van Wering, E. R., and van Dongen, J. J. M. (1999) Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor alpha beta lineage. Blood 93, 4079-4085. (Pubitemid 29279249)
17. Szczepanski, T., Willemse, M. J., van Wering, E. R., van Weerden, J. F., Kamps, W. A., and van Dongen, J. J. M. (2001) Precursor-B-ALL with D(H)-J(H) gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14. Leukemia 15, 1415-1423. (Pubitemid 32785311)
18. Beishuizen, A., Hahlen, K., Hagemeijer, A., Verhoeven, M. A., Hooijkaas, H., Adriaansen, H. J., Wolvers-Tettero, I. L., van Wering, E. R., and van Dongen, J. J. (1991) Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukemia of precursor B-cell origin. Leukemia 5, 657-667.
19. Beishuizen, A., de Bruijn, M. A., Pongers-Wil- lemse, M. J., Verhoeven, M. A., van Wering, E. R., Hahlen, K., Breit, T. M., de Bruin-Versteeg, S., Hooijkaas, H., and van Dongen, J. J. (1997) Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease. Leukemia 11, 2200-2207. (Pubitemid 28043710)
20. Bruggemann, M., van der Velden, V. H. J., Raff, T., Droese, J., Ritgen, M., Pott, C., Wijkhuijs, A., Goekbuget, N., Hoelzer, D., van Wering, E. R., van Dongen, J. J. M., and Kneba, M. (2004) Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease (MRD) in childhood and adult T-cell acute lymphoblastic leukemia (T-ALL). Leukemia 18, 709-719. (Pubitemid 38528651)
21. Brumpt, C., Delabesse, E., Beldjord, K., Davi, F., Cayuela, J. M., Millien, C., Villarese, P., Quartier, P., Buzyn, A., Valensi, F., and Mac-intyre, E. (2000) The incidence of clonal T-cell receptor rearrangements in B-cell precursor acute lymphoblastic leukemia varies with age and genotype. Blood 96, 2254-2261.
22. Huebner, S., Cazzaniga, G., Flohr, T., van der Velden, V. H. J., Konrad, M., Basso, G., Schrappe, M., van Dongen, J. J. M., Bartram, C., Biondi, A., and Panzer-Gruemayer, E. (2004) High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1 positive leukemias. Leukemia 18, 84-91. (Pubitemid 38159443)
23. Jansen, M. W., Corral, L., van der Velden, V. H., Panzer-Grumayer, R., Schrappe, M., Schrauder, A., Marschalek, R., Meyer, C., den Boer, M. L., Hop, W. J., Valsecchi, M. G., Basso, G., Biondi, A., Pieters, R., and van Dongen, J. J. (2007) Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. Leukemia 21, 633-641. (Pubitemid 46444545)
24. Mann, G., Cazzaniga, G., van der Velden, V. H., Flohr, T., Csinady, E., Paganin, M., Schrauder, A., Dohnal, A. M., Schrappe, M., Biondi, A., Gadner, H., van Dongen, J. J., and Panzer-Grumayer, E. R. (2007) Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The 'big sister' of the infant disease? Leukemia 21, 642-646. (Pubitemid 46444546)
25. van der Velden, V. H., de Bie, M., van Wering, E. R., and van Dongen, J. J. (2006) Immu-noglobulin light chain gene rearrangements in precursor-B-acute lymphoblastic leukemia: characteristics and applicability for the detection of minimal residual disease. Haematolog-ica 91, 679-682. (Pubitemid 43799469)
26. van der Velden, V. H. J., Bruggemann, M., Hoogeveen, P. G., de Bie, M., Hart, P. G., Raff, T., Pfeifer, H., Luschen, S., Szczepan-ski, T., van Wering, E. R., Kneba, M., and van Dongen, J. J. M. (2004) TCRB gene rearrangements in childhood and adult precursor-B-ALL: frequency, applicability as MRD-PCR target, and stability between diagnosis and relapse. Leukemia 18, 1971-1980. (Pubitemid 40028423)
27. Van Der Velden, V. H. J., Szczepanski, T., Wijkhuijs, J. M., Hart, P. G., Hoogeveen, P. G., Hop, W. C., Van Wering, E. R., and Van Dongen, J. J. M. (2003) Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual disease. Leukemia 17, 1834-1844. (Pubitemid 37185260)
28. van der Velden, V. H. J., Wijkhuijs, J. M., Jacobs, D. C., van Wering, E. R., and van Dongen, J. J. M. (2002) T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis. Leukemia 16, 1372-1380.
29. van der Velden, V. H. J., Willemse, M. J., van der Schoot, C. E., Hahlen, K., van Wering, E. R., and van Dongen, J. J. M. (2002) Immu-noglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR. Leukemia 16, 928-936. (Pubitemid 34537567)
30. Pongers-Willemse, M. J., Seriu, T., Stolz, F., d'Aniello, E., Gameiro, P., Pisa, P., Gonzalez, M., Bartram, C. R., Panzer-Grumayer, E. R., Biondi, A., San Miguel, J. F., and van Dongen, J. J. M. (1999) Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia. Leukemia 13, 110-118. (Pubitemid 29043725)
31. Kuppers, R., Zhao, M., Rajewsky, K., and Hansmann, M. L. (1993) Detection of clonal B cell populations in paraffin-embedded tissues by polymerase chain reaction. American Journal of Pathology 143, 230-239. (Pubitemid 24058177)
32. van Dongen, J. J. M., Langerak, A. W., Brug- gemann, M., Evans, P. A. S., Hummel, M., Lavender, F. L., Delabesse, E., Davi, F., Schuuring, E., Garcia Sanz, R., van Krieken, J. H. J. M., Droese, J., Gonzalez, D., Bastard, C., White, H. E., Spaargaren, M., Gonzalez Diaz, M., Parreira, A., Smith, J. L., Morgan, G. J., Kneba, M., and Macintyre, E. A. (2003) Design and standardization of PCR primers and protocols for detection of clonal immu-nogloulin and T-cell receptor gene recombinations in suspect lymphoproliferations. Leukemia 17, 2257-2317. (Pubitemid 38072572)
33. Feldhahn, N., Henke, N., Melchior, K., Duy, C., Soh, B. N., Klein, F., von Levetzow, G., Giebel, B., Li, A., Hofmann, W. K., Jumaa, H., and Muschen, M. (2007) Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblas-tic leukemia cells. The Journal of Experimental Medicine 204, 1157-1166. (Pubitemid 46798158)
34. de Haas, V., Verhagen, O. J., von dem Borne, A. E., Kroes, W., van den Berg, H., and van der Schoot, C. E. (2001) Quantification of minimal residual disease in children with oli-goclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy. Leukemia 15, 134-140. (Pubitemid 32140326)
35. Konrad, M., Metzler, M., Panzer, S., Ost- reicher, I., Peham, M., Repp, R., Haas, O. A., Gadner, H., and Panzer-Grumayer, E. R. (2003) Late relapses evolve from slow-re sponding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the per sistence of a preleukemic clone. Blood 101, 3635-3640. (Pubitemid 36857953)
36. van Dongen, J. J. and Wolvers-Tettero, I. L. (1991) Analysis of immunoglobulin and T cell receptor genes. Part I: Basic and technical aspects. Clinical Chimica Acta 198, 1-91.
37. Li, A., Zhou, J., Zuckerman, D., Rue, M., Dalton, V., Lyons, C., Silverman, L. B., Sal-lan, S. E., and Gribben, J. G. (2003) Sequence analysis of clonal immunoglobulin and T-cell receptor gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: implications for pathogenesis and for the clinical utility of PCR-based methods of minimal residual disease detection. Blood 102, 4520-4526. (Pubitemid 37494119)
38. Szczepanski, T., van der Velden, V. H. J., Raff, T., Jacobs, D. C. H., van Wering, E. R., Brüggemann, M., Kneba, M., and van Dongen, J. J. M. (2003) Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphob-lastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of secondary T-ALL. Leukemia 17, 2149-2156. (Pubitemid 37428380)
39. Szczepanski, T., Willemse, M. J., Brinkhof, B., van Wering, E. R., van der Burg, M., and van Dongen, J. J. M. (2002) Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-BALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease. Blood 99, 2315-2323. (Pubitemid 34525415)
40. Verhagen, O. J., Willemse, M. J., Breunis, W. B., Wijkhuijs, A. J., Jacobs, D. C., Joosten, S. A., van Wering, E. R., van Dongen, J. J. M., and van der Schoot, C. E. (2000) Application of germline IGH probes in real-time quantita tive PCR for the detection of minimal resid ual disease in acute lymphoblastic leukemia. Leukemia 14, 1426-1435. (Pubitemid 30599324)
41. Br uggemann, M., Droese, J., Bolz, I., Luth, P., Pott, C., von Neuhof f, N., Scheuering, U., and Kneba, M. (2000) Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR. Leukemia 14, 1419-1425. (Pubitemid 30599323)
42. Breit, T. M., Beishuizen, A., Ludwig, W. D., Mol, E. J., Adriaansen, H. J., van Wering, E. R., and van Dongen, J. J. (1993) tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease. Leukemia 7, 2004-2011. (Pubitemid 24003220)
43. Breit, T. M., Mol, E. J., Wolvers-Tettero, I. L., Ludwig, W. D., van Wering, E. R., and van Dongen, J. J. (1993) Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes. The Journal of Experimental Medicine 177, 965-977. (Pubitemid 23097386)
44. Szczepanski, T., van der Velden, V. H. J., and van Dongen, J. J. M. (2002) real-time quantitative (RQ)-PCR for the detection of minimal residual disease in childhood acute lymphob-lastic leukemia. Haematologica 87 (suppl. 1), 183-191.
45. Langerak, A. W., Wolvers-Tettero, I. L., van Gastel-Mol, E. J., Oud, M. E., and van Dongen, J. J. (2001) Basic helix-loop-helix proteins E2A and HEB induce immature T-cell receptor rearrangements in nonlymphoid cells. Blood 98, 2456-2465.
46. van der Velden, V. H., Cazzaniga, G., Schrauder, A., Hancock, J., Bader, P., Panzer-Grumayer, E. R., Flohr, T., Sutton, R., Cave, H., Madsen, H. O., Cayuela, J. M., Trka, J., Eckert, C., Foroni, L., Zur Stadt, U., Beld-jord, K., Raff, T., van der Schoot, C. E., and van Dongen, J. J. (2007) Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of realtime quantitative PCR data. Leukemia 21, 604-611. (Pubitemid 46444541)
47. Verhagen, O. J., Wijkhuijs, A. J., van der Sluijs-Gelling, A. J., Szczepanski, T., van der Linden-Schrever, B. E., Pongers-Willemse, M. J., van Wering, E. R., van Dongen, J. J. M., and van der Schoot, C. E. (1999) Suitable DNA isolation method for the detection of minimal residual disease by PCR techniques. Leukemia 13, 1298-1299. (Pubitemid 29396597)
48. Pongers-Willemse, M. J., Verhagen, O. J., Tibbe, G. J., Wijkhuijs, A. J., de Haas, V., Roovers, E., van der Schoot, C. E., and van Dongen, J. J. M. (1998) Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia 12, 2006-2014. (Pubitemid 28554473)
49. Beishuizen, A., Verhoeven, M. A., Mol, E. J., Breit, T. M., Wolvers-Tettero, I. L., and van Dongen, J. J. (1993) Detection of immu-noglobulin heavy-chain gene rearrangements by Southern blot analysis: recommendations for optimal results. Leukemia 7, 2045-2053. (Pubitemid 24003226)
50. Beishuizen, A., Verhoeven, M. A., Mol, E. J., and van Dongen, J. J. (1994) Detection of immunoglobulin kappa light-chain gene rearrangement patterns by Southern blot analysis. Leukemia 8, 2228-2236.
51. Breit, T. M., Wolvers-Tettero, I. L., Beishui- zen, A., Verhoeven, M. A., van Wering, E. R., and van Dongen, J. J. (1993) Southern blot patterns, frequencies, and junctional diversity of T-cell receptor-delta gene rearrangements in acute lymphoblastic leukemia. Blood 82, 3063-3074. (Pubitemid 23334933)
52. van Wering, E. R., van der Linden-Schrever, B. E., van der Velden, V. H. J., Szczepanski, T., and van Dongen, J. J. M. (2001) T-lym-phocytes in bone marrow samples of children with acute lymphoblastic leukemia during and after chemotherapy might hamper PCR-based minimal residual disease studies. Leukemia 15, 1301-1303. (Pubitemid 32776457)
53. van Wering, E. R., van der Linden-Schrever, B. E., Szczepanski, T., Willemse, M. J., Baars, E. A., van Wijngaarde-Schmitz, H. M., Kamps, W. A., and van Dongen, J. J. M. (2000) Regenerating normal B-cell precursors during and after treatment of acute lymphob-lastic leukaemia: implications for monitoring of minimal residual disease. British Journal of Haematology 110, 139-146. (Pubitemid 30627499)
54. van Lochem, E. G., Wiegers, Y. M., van den Beemd, R., Hahlen, K., van Dongen, J. J. M., and Hooijkaas, H. (2000) Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy. Leukemia 14, 688-695. (Pubitemid 30195461)
55. Van der Velden, V. H. J., Wijkhuijs, J. M., and Van Dongen, J. J. M. (2008) Non-specific amplification of patient-specific Ig/TCR gene rearrangements depends on the time point during therapy: implications for minimal residual disease monitoring. Leukemia 22, 641-644. (Pubitemid 351386738)
56. van der Velden, V. H., Hoogeveen, P. G., Pieters, R., and van Dongen, J. J. (2006) Impact of two independent bone marrow samples on minimal residual disease monitoring in childhood acute lymphoblastic leukaemia. British Journal of Haematolology 133, 382-388.
57. van der Velden, V. H. J., Jacobs, D. C., Wijkhuijs, A. J., Comans-Bitter, W. M., Wil-lemse, M. J., Hahlen, K., Kamps, W. A., van Wering, E. R., and van Dongen, J. J. M. (2002) Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL. Leukemia 16, 1432-1436.
58. Moppett, J., van der Velden, V. H., Wijkhuijs, A. J., Hancock, J., van Dongen, J. J., and Goulden, N. (2003) Inhibition affecting RQ-PCR-based assessment of minimal residual disease in acute lymphoblastic leukemia: Reversal by addition of bovine serum albumin. Leukemia 17, 268-270. (Pubitemid 36175921)